Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
3.270
-0.130 (-3.82%)
Mar 6, 2026, 10:14 AM EST - Market open
Evolent Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 1,876 | 2,555 | 1,964 | 1,352 | 907.96 | Upgrade
|
| Revenue Growth (YoY) | -26.56% | 30.09% | 45.26% | 48.91% | -1.80% | Upgrade
|
| Cost of Revenue | 1,476 | 2,187 | 1,503 | 1,035 | 657.55 | Upgrade
|
| Gross Profit | 399.88 | 367.35 | 460.47 | 316.58 | 250.41 | Upgrade
|
| Selling, General & Admin | 288.47 | 246.64 | 322.87 | 269.27 | 207.78 | Upgrade
|
| Operating Expenses | 404.32 | 343.41 | 446.29 | 336.46 | 267.82 | Upgrade
|
| Operating Income | -4.44 | 23.94 | 14.18 | -19.88 | -17.41 | Upgrade
|
| Interest Expense | -57.47 | -24.72 | -54.21 | -15.57 | -25.43 | Upgrade
|
| Interest & Investment Income | 4.19 | 5.54 | 5.26 | 1.37 | 0.41 | Upgrade
|
| Earnings From Equity Investments | 0.37 | -3.44 | 1.29 | 4.57 | 13.18 | Upgrade
|
| Other Non Operating Income (Expenses) | -53.1 | 0.07 | -62.53 | -45.89 | -0.15 | Upgrade
|
| EBT Excluding Unusual Items | -110.45 | 1.39 | -96 | -75.41 | -29.4 | Upgrade
|
| Merger & Restructuring Charges | -5.25 | -13.53 | -35.24 | - | -11.72 | Upgrade
|
| Impairment of Goodwill | -398 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 14.87 | - | -8.11 | - | 45.94 | Upgrade
|
| Asset Writedown | - | -24.19 | -24.07 | - | - | Upgrade
|
| Other Unusual Items | -35.8 | -26.71 | -38.99 | 13.33 | -34.62 | Upgrade
|
| Pretax Income | -534.64 | -63.04 | -202.41 | -62.08 | -29.8 | Upgrade
|
| Income Tax Expense | -0.13 | -1.41 | -89.37 | -43.38 | 0.48 | Upgrade
|
| Earnings From Continuing Operations | -534.51 | -61.62 | -113.04 | -18.7 | -30.28 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | -0.46 | -7.32 | Upgrade
|
| Net Income to Company | -534.51 | -61.62 | -113.04 | -19.16 | -37.6 | Upgrade
|
| Net Income | -534.51 | -61.62 | -113.04 | -19.16 | -37.6 | Upgrade
|
| Preferred Dividends & Other Adjustments | 44.89 | 31.83 | 29.22 | - | - | Upgrade
|
| Net Income to Common | -579.4 | -93.45 | -142.26 | -19.16 | -37.6 | Upgrade
|
| Shares Outstanding (Basic) | 114 | 115 | 111 | 94 | 86 | Upgrade
|
| Shares Outstanding (Diluted) | 114 | 115 | 111 | 94 | 86 | Upgrade
|
| Shares Change (YoY) | -0.41% | 3.08% | 18.73% | 8.87% | 1.34% | Upgrade
|
| EPS (Basic) | -5.07 | -0.81 | -1.28 | -0.20 | -0.44 | Upgrade
|
| EPS (Diluted) | -5.07 | -0.81 | -1.28 | -0.20 | -0.44 | Upgrade
|
| Free Cash Flow | 4.76 | -14.35 | 113.84 | -59.08 | 11.25 | Upgrade
|
| Free Cash Flow Per Share | 0.04 | -0.13 | 1.02 | -0.63 | 0.13 | Upgrade
|
| Gross Margin | 21.31% | 14.38% | 23.45% | 23.42% | 27.58% | Upgrade
|
| Operating Margin | -0.24% | 0.94% | 0.72% | -1.47% | -1.92% | Upgrade
|
| Profit Margin | -30.88% | -3.66% | -7.24% | -1.42% | -4.14% | Upgrade
|
| Free Cash Flow Margin | 0.25% | -0.56% | 5.80% | -4.37% | 1.24% | Upgrade
|
| EBITDA | 88.22 | 95.11 | 110.9 | 20.32 | 16.13 | Upgrade
|
| EBITDA Margin | 4.70% | 3.72% | 5.65% | 1.50% | 1.78% | Upgrade
|
| D&A For EBITDA | 92.65 | 71.17 | 96.72 | 40.2 | 33.54 | Upgrade
|
| EBIT | -4.44 | 23.94 | 14.18 | -19.88 | -17.41 | Upgrade
|
| EBIT Margin | -0.24% | 0.94% | 0.72% | -1.47% | -1.92% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.